Position in PRAX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$34,940,216
+$8,649,409 QoQ
Shares Held
108,446
+21.6% QoQ
Ownership
0.389%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 99.73535215683381.ToString("F0")%
Shared 0.ToString("F0")%
None 0.2646478431661841.ToString("F0")%
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Derivatives in PRAX
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$1,858,610
PutShares
44,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,306,928,575 across 560 Biotechnology names. PRAX ranks #50 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in PRAX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,940,216 | 108,446 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $26,290,807 | 89,200 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $5,131,036 | 96,812 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,858,610 | 44,200 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $3,638,754 | 86,534 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,704,150 | 45,000 | Put | Defined | 2025-05-13 | |
| 2025-03-31 | $7,305,463 | 192,909 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $9,255,748 | 120,267 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,700,306 | 29,550 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,107,496 | 26,777 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $488 | 8 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $60,133 | 2,699 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||